This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States Government as Represented by the Department of Veterans Affairs. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Kenneth Iczkowski: Innovator in Prostate Cancer Research
Introduction
Kenneth Iczkowski is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of medical research, particularly in the area of prostate cancer. His work focuses on the genetic markers that can aid in the detection and prognosis of this prevalent disease.
Latest Patents
Kenneth Iczkowski holds a patent titled "Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer." This invention relates to the risk assessment, detection, diagnosis, or prognosis of prostate cancer. More specifically, it involves the detection of certain polymorphisms in the promoter region of the MIF gene to determine the risk, detect, diagnose, or prognosticate prostate cancer. The findings indicate that the presence of a 1 patent and/or −749 (CATT) repeat predisposes an individual to prostate cancer.
Career Highlights
Kenneth Iczkowski is affiliated with the United States Government as represented by the Department of Veterans Affairs. His role in this esteemed organization underscores his commitment to advancing medical research and improving patient outcomes.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues such as Katherine Meyer Siegler and Richard J Bucala. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Kenneth Iczkowski's innovative work in identifying genetic markers for prostate cancer exemplifies the critical intersection of research and clinical application. His contributions are vital in the ongoing fight against this disease, and his patent reflects a significant step forward in medical science.